359 related articles for article (PubMed ID: 28036289)
1. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
[TBL] [Abstract][Full Text] [Related]
2. Expression Patterns of TRPC1 in Cortical Lesions from Patients with Focal Cortical Dysplasia.
Zang Z; Li S; Zhang W; Chen X; Zheng D; Shu H; Guo W; Zhao B; Shen K; Wei Y; Zheng X; Liu S; Yang H
J Mol Neurosci; 2015 Oct; 57(2):265-72. PubMed ID: 26280213
[TBL] [Abstract][Full Text] [Related]
3. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
[TBL] [Abstract][Full Text] [Related]
4. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
[TBL] [Abstract][Full Text] [Related]
5. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex.
Wang LK; Chen X; Zhang CQ; Liang C; Wei YJ; Yue J; Liu SY; Yang H
J Mol Neurosci; 2017 Jun; 62(2):222-231. PubMed ID: 28455787
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of fibroblast growth factor 13 in cortical lesions of the focal cortical dysplasia.
Wu K; Yue J; Shen K; He J; Zhu G; Liu S; Zhang C; Yang H
Brain Res Bull; 2021 Mar; 168():36-44. PubMed ID: 33285262
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II.
Zhang Z; Liu Q; Liu M; Wang H; Dong Y; Ji T; Liu X; Jiang Y; Cai L; Wu Y
J Neuroinflammation; 2018 Jan; 15(1):27. PubMed ID: 29382328
[TBL] [Abstract][Full Text] [Related]
9. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
Knerlich-Lukoschus F; Connolly MB; Hendson G; Steinbok P; Dunham C
J Neurosurg Pediatr; 2017 Feb; 19(2):182-195. PubMed ID: 27885945
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb.
Yu S; Li S; Shu H; Zhang C; He J; Fan X; Yang H
Neuroreport; 2012 May; 23(7):407-11. PubMed ID: 22494998
[TBL] [Abstract][Full Text] [Related]
11. Type IIB focal cortical dysplasia with balloon cells in medial temporal lobe epilepsy: Clinical, neuroimaging, and histopathological findings.
Mao C; Jin L; Dou W; Lu Q; Zhou L; Ren H; Zhao Y; Feng F; Guo Y; Gao J
Epilepsy Res; 2019 Nov; 157():106189. PubMed ID: 31472401
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated expression of acid-sensing ion channel 1a in cortical lesions of patients with focal cortical dysplasia.
Guo W; Chen X; He JJ; Wei YJ; Zang ZL; Liu SY; Yang H; Zhang CQ
J Mol Neurosci; 2014 Jun; 53(2):176-82. PubMed ID: 24682892
[TBL] [Abstract][Full Text] [Related]
13. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs).
Sugiura C; Miyata H; Ueda M; Ohama E; Vinters HV; Ohno K
Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
[TBL] [Abstract][Full Text] [Related]
16. Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia.
Aronica E; Gorter JA; Jansen GH; van Veelen CW; van Rijen PC; Ramkema M; Troost D
Epilepsia; 2003 Jun; 44(6):785-95. PubMed ID: 12790891
[TBL] [Abstract][Full Text] [Related]
17. The interleukin 17 system in cortical lesions in focal cortical dysplasias.
He JJ; Li S; Shu HF; Yu SX; Liu SY; Yin Q; Yang H
J Neuropathol Exp Neurol; 2013 Feb; 72(2):152-63. PubMed ID: 23334598
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
van Scheppingen J; Broekaart DW; Scholl T; Zuidberg MR; Anink JJ; Spliet WG; van Rijen PC; Czech T; Hainfellner JA; Feucht M; Mühlebner A; van Vliet EA; Aronica E
J Neuroinflammation; 2016 Aug; 13(1):202. PubMed ID: 27566410
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of neuropeptide Y receptors caused by focal cortical dysplasia in human intractable epilepsy.
Li L; Deng J; Liu C; Luo H; Guan Y; Zhou J; Qi X; Li T; Xu ZD; Luan GM
Oncotarget; 2016 Mar; 7(13):15329-38. PubMed ID: 26943580
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy in focal cortical dysplasia at 3T.
Tschampa HJ; Urbach H; Träber F; Sprinkart AM; Greschus S; Malter MP; Surges R; Gieseke J; Block W
Seizure; 2015 Nov; 32():23-9. PubMed ID: 26552557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
